- Home
- WLKP vs ABUS Comparison
WLKP vs ABUS Comparison
Compare WLKP & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- ABUS
- Stock Information
- Founded
- WLKP 2014
- ABUS N/A
- Country
- WLKP United States
- ABUS United States
- Employees
- WLKP N/A
- ABUS N/A
- Industry
- WLKP Major Chemicals
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- WLKP Industrials
- ABUS Health Care
- Exchange
- WLKP Nasdaq
- ABUS Nasdaq
- Market Cap
- WLKP 791.6M
- ABUS 725.9M
- IPO Year
- WLKP 2014
- ABUS N/A
- Fundamental
- Price
- WLKP $23.08
- ABUS $3.46
- Analyst Decision
- WLKP
- ABUS Strong Buy
- Analyst Count
- WLKP 0
- ABUS 4
- Target Price
- WLKP N/A
- ABUS $5.50
- AVG Volume (30 Days)
- WLKP 43.3K
- ABUS 837.4K
- Earning Date
- WLKP 11-05-2024
- ABUS 11-06-2024
- Dividend Yield
- WLKP 8.20%
- ABUS N/A
- EPS Growth
- WLKP 8.66
- ABUS N/A
- EPS
- WLKP 1.75
- ABUS N/A
- Revenue
- WLKP $1,143,109,000.00
- ABUS $6,742,000.00
- Revenue This Year
- WLKP N/A
- ABUS N/A
- Revenue Next Year
- WLKP $5.56
- ABUS N/A
- P/E Ratio
- WLKP $12.97
- ABUS N/A
- Revenue Growth
- WLKP N/A
- ABUS N/A
- 52 Week Low
- WLKP $21.19
- ABUS $1.79
- 52 Week High
- WLKP $23.68
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- WLKP 65.20
- ABUS 30.63
- Support Level
- WLKP $22.43
- ABUS $3.42
- Resistance Level
- WLKP $23.07
- ABUS $3.81
- Average True Range (ATR)
- WLKP 0.35
- ABUS 0.16
- MACD
- WLKP 0.04
- ABUS -0.04
- Stochastic Oscillator
- WLKP 100.00
- ABUS 7.41
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.